ATE305447T1 - NEW FATTY ACID ANALOGUES - Google Patents

NEW FATTY ACID ANALOGUES

Info

Publication number
ATE305447T1
ATE305447T1 AT01910259T AT01910259T ATE305447T1 AT E305447 T1 ATE305447 T1 AT E305447T1 AT 01910259 T AT01910259 T AT 01910259T AT 01910259 T AT01910259 T AT 01910259T AT E305447 T1 ATE305447 T1 AT E305447T1
Authority
AT
Austria
Prior art keywords
carbon
fatty acid
alkyl
coor2
proviso
Prior art date
Application number
AT01910259T
Other languages
German (de)
Inventor
Rolf Berge
Leiv K Sydnes
Jon Songstad
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Application granted granted Critical
Publication of ATE305447T1 publication Critical patent/ATE305447T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)

Abstract

The present invention relates to novel fatty acid analogous of the general formula (I): R1—[xi—CH2]n—COOR2 wherein R1 is: a C6-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C6-C24 alkyne, and/or a C6-C24 alkyl substituted in one or several positions with one or more compounds selected from the group comprising fluoride, chloride, hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C2-C5 acyloxy or C1-C4 alkyl, and wherein R2 represents hydrogen or C1-C4 alkyl, and wherein n is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR2, and wherein Xi independent of each other are selected from the group comprising O, S, SO, SO2, Se and CH2, and with the proviso that at least one of the Xi is not CH2, and with the proviso that if R1 is an alkye, then the carbon-carbon triple bond is positioned between the (ω-1) carbon and the (ω-2) carbon, or between the (ω-2) carbon and the (ω-3) carbon, or between the (ω-3) carbon and the (ω-4) carbon, a salt, prodrug or complex thereof, which can be used for the treatment and/or prevention of syndrome X, obesity, hypertension, fatty liver, diabetes, hyperglycaemia, hyperinsulinemia and stenosis. Further, the invention relates to a nutritional composition comprising said fatty acid analogues, and a method for reducing the total weight, or the amount of adipose tissue in an animal.
AT01910259T 2000-03-03 2001-03-02 NEW FATTY ACID ANALOGUES ATE305447T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20001123A NO328803B1 (en) 2000-03-03 2000-03-03 New fatty acid analogues
PCT/NO2001/000082 WO2001068582A1 (en) 2000-03-03 2001-03-02 Novel fatty acid analogous

Publications (1)

Publication Number Publication Date
ATE305447T1 true ATE305447T1 (en) 2005-10-15

Family

ID=19910832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01910259T ATE305447T1 (en) 2000-03-03 2001-03-02 NEW FATTY ACID ANALOGUES

Country Status (18)

Country Link
US (1) US7902399B2 (en)
EP (1) EP1265838B9 (en)
JP (1) JP5122050B2 (en)
KR (3) KR100857626B1 (en)
CN (1) CN1283611C (en)
AT (1) ATE305447T1 (en)
AU (2) AU2001237835B2 (en)
BR (1) BR0108950A (en)
CA (1) CA2401757C (en)
DE (1) DE60113663T2 (en)
DK (1) DK1265838T3 (en)
ES (1) ES2250360T3 (en)
HK (1) HK1050182A1 (en)
MX (1) MX236472B (en)
NO (1) NO328803B1 (en)
NZ (1) NZ521137A (en)
RU (1) RU2288215C2 (en)
WO (1) WO2001068582A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20004844L (en) * 2000-09-27 2002-05-10 Thia Medica As Fatty acid analogues for the treatment of proliferative skin diseases
CN100351259C (en) * 2002-06-20 2007-11-28 Icvec有限公司 Sulfur-containing phospholipid derivatives
CA2554735A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
NO324533B1 (en) * 2004-07-19 2007-11-19 Thia Medica As Material prepared from a combination of non-β-oxidizable fatty acid analogues and a protein material, as well as the use thereof.
MX2007000813A (en) * 2004-07-19 2007-06-05 Thia Medica As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities.
ES2733353T3 (en) 2007-11-09 2019-11-28 Basf As Lipid compounds for use in cosmetic products, as a food supplement or as a medicine
NO20075894L (en) * 2007-11-15 2009-05-18 Thia Medica As Reduced maturation in fish
EP2147910A1 (en) * 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
CA2760877C (en) 2009-05-08 2020-09-08 Pronova Biopharma Norge As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
ES2618604T3 (en) 2010-11-05 2017-06-21 Pronova Biopharma Norge As Methods of treatment using lipid compounds
WO2014132134A1 (en) 2013-02-28 2014-09-04 Pronova Biopharma Norge As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
CA3052449C (en) 2013-03-11 2021-10-19 Jan Remmereit Lipid compositions comprising 5, 11, 14-eicosatrienoic acid and conjugated linoleic acids
CA2904827C (en) 2013-03-11 2020-10-27 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
AU2016256552B2 (en) 2015-04-28 2021-04-01 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
KR20200096791A (en) 2017-12-06 2020-08-13 바스프 에이에스 Fatty acid derivatives for the treatment of non-alcoholic steatohepatitis

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210230A1 (en) * 1972-03-03 1973-09-06 Kolmar Laboratories Antimicrobial and cytostatic thioethers - contg a polar residue
BE809894A (en) * 1973-01-30 1974-07-18 ANTI-COLOR DIAPER FABRICS FOR PHOTOGRAPHIC COLOR MATERIALS
JPS5531778B2 (en) * 1973-02-15 1980-08-20
DE3620685A1 (en) 1986-06-20 1987-12-23 Henkel Kgaa NEW AGENTS FOR COVERING INJURED AND / OR INJURED AREAS OF HUMAN OR ANIMAL SKIN
IL87183A (en) 1987-07-22 1995-05-26 Roussel Uclaf 1, 4-disubstituted bicyclo (2.2.2) octane derivatives, their preparation and their use as pesticides
FR2631339B1 (en) 1988-05-10 1990-11-16 Cird NOVEL SULFID EICOSANOIDES AND THEIR APPLICATION IN PHARMACY AND COSMETICS
US5268494A (en) * 1988-05-10 1993-12-07 Centre International De Recherches Dermatologiques C.I.R.D. Sulphur-containing eicosanoides and their application in pharmacy and in cosmetics
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
JPH0379659A (en) 1989-08-22 1991-04-04 Mitsubishi Gas Chem Co Inc Molding material for optical application
SG43007A1 (en) 1989-09-11 1997-10-17 Kao Corp Bleaching composition
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
JP3079659B2 (en) 1991-08-07 2000-08-21 松下電器産業株式会社 Automotive air purifier
US6602861B1 (en) 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5290960A (en) * 1993-02-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Navy Diacetylenic phospholipids containing heteroatom near diacetylenic functionality for modulation of microstructure morphology
DE69524639T2 (en) * 1994-10-13 2002-08-08 Peptech Ltd MODIFIED MULTIPLE UNSATURATED FATTY ACIDS
NO952796D0 (en) * 1995-07-14 1995-07-14 Rolf Berge Fatty acid analogues with non-oxidizable B-site, preparation and use in crepes
WO1997038688A1 (en) * 1996-04-12 1997-10-23 Peptide Technology Pty. Limited Methods of treating immunopathologies using polyunsaturated fattyacids
CA2257084A1 (en) * 1996-06-06 1997-12-11 Anthony H. Cincotta Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
AU754086B2 (en) * 1998-06-29 2002-11-07 Parker Hughes Institute Alkyl ketones as potent anti-cancer agents
WO2000030444A1 (en) 1998-11-25 2000-06-02 Vanderbilt University Cationic liposomes for gene transfer
FR2792312B1 (en) 1999-04-15 2001-06-08 Oreal THIA-ALCYNOIC (POLY) COMPOUNDS AND DERIVATIVES THEREOF, COMPOSITIONS COMPRISING SAME AND THEIR USE
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO20003591L (en) 2000-07-13 2002-01-14 Thia Medica As Fatty acid analogues for the treatment of cancer
NO20004844L (en) 2000-09-27 2002-05-10 Thia Medica As Fatty acid analogues for the treatment of proliferative skin diseases
NO20006008L (en) 2000-11-28 2002-05-29 Thia Medica As Fatty acid analogues for the treatment of inflammatory and autoimmune diseases
US20020188023A1 (en) * 2000-12-12 2002-12-12 Michael Jorgensen Compound
GB0118517D0 (en) * 2001-07-30 2001-09-19 Mitsubishi Tokyo Pharm Inc Compound
FR2828487B1 (en) * 2001-08-09 2005-05-27 Genfit S A NOVEL COMPOUNDS DERIVED FROM FATTY ACIDS, PREPARATION AND USES
CN100351259C (en) 2002-06-20 2007-11-28 Icvec有限公司 Sulfur-containing phospholipid derivatives
MX2007000813A (en) * 2004-07-19 2007-06-05 Thia Medica As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities.

Also Published As

Publication number Publication date
HK1050182A1 (en) 2003-06-13
ES2250360T3 (en) 2006-04-16
RU2288215C2 (en) 2006-11-27
JP2003527364A (en) 2003-09-16
US7902399B2 (en) 2011-03-08
WO2001068582A1 (en) 2001-09-20
AU2001237835B2 (en) 2006-03-23
KR20020077931A (en) 2002-10-14
KR20090108135A (en) 2009-10-14
KR100982228B1 (en) 2010-09-14
EP1265838B9 (en) 2006-05-10
CN1283611C (en) 2006-11-08
NZ521137A (en) 2004-08-27
NO20001123D0 (en) 2000-03-03
BR0108950A (en) 2003-01-28
US20040213442A1 (en) 2004-10-28
KR100857626B1 (en) 2008-09-08
DE60113663D1 (en) 2006-02-09
EP1265838A1 (en) 2002-12-18
CA2401757C (en) 2010-09-14
NO20001123L (en) 2001-09-04
CA2401757A1 (en) 2001-09-20
KR20080046747A (en) 2008-05-27
NO328803B1 (en) 2010-05-18
DK1265838T3 (en) 2006-02-20
MX236472B (en) 2006-05-04
JP5122050B2 (en) 2013-01-16
AU3783501A (en) 2001-09-24
KR100940373B1 (en) 2010-02-02
RU2002123590A (en) 2004-02-27
DE60113663T2 (en) 2006-07-27
MXPA02008629A (en) 2003-09-22
EP1265838B1 (en) 2005-09-28
CN1419532A (en) 2003-05-21

Similar Documents

Publication Publication Date Title
ATE305447T1 (en) NEW FATTY ACID ANALOGUES
ATE548919T1 (en) FAT OR OIL COMPOSITION
ATE516321T2 (en) COMPOSITIONS CONTAINING FLUOROSUBSTITUTED OLEFINS
KR900012592A (en) Dental fillings
HUP0002174A2 (en) Composition containing humidity regulators, for tissue products
EP2336287A3 (en) Compositions containing fluorine substituted olefins
EP2277977A3 (en) Compositions containing fluorine substituted olefins
BR9910296A (en) New fatty analogs for the treatment of obesity, hypertension and fat in the liver
WO2005089256A3 (en) Antiangiogenic agents
DE60100849D1 (en) NEW PHOSPHORIC CONNECTIONS
WO2007010281A3 (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
NO20043548L (en) Use of polyunsaturated cotton for the treatment of psoriasis
ATE418974T1 (en) FATTY ACID ANALOGUES FOR THE TREATMENT OF PROLIFERATIONAL SKIN DISORDERS
WO2005118636A3 (en) Tgf derepressors and uses related thereto
MXPA02012944A (en) Fatty acid analogues for the treatment of cancer.
RU2000103224A (en) DEPRIVATED SIDE EFFECTS Derivatives of prostaglandins for the treatment of glaucoma
JP2010520242A5 (en)
BRPI0601283A (en) floor covering composition, floor coating composition additive, leveling agent or plasticizer, and method for improving the leveling performance of a floor covering composition
EP1264594A3 (en) Melanin production inhibitors and skincare products containing such inhibitors
BR0214917A (en) Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
CY1107756T1 (en) Sulfate Analogs of 21-Hydroxy-6, 19-Oxidoprogesterone (21OH-6OP)
WO2003009820B1 (en) Methods for promotion of hair growth comprising topical application of prostaglandin analogues
WO2007061314A3 (en) Use of fatty acid analogues
BRPI0410926A (en) 3-oxa-8-azaprostaglandins analogues as agents for reducing intraocular pressure
IL145076A0 (en) Novel intermediate for the synthesis of prostaglandins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265838

Country of ref document: EP